搜索临床试验以:CEP-701 60毫克
总计7300个结果
-
Regeneron PharmaceuticalsBristol-Myers Squibb主动,不招人
-
Electromedical Products International, Inc.University of Nottingham招聘中
-
The University of Texas Health Science Center,...完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止IV 期胰腺癌 AJCC v8 | 转移性胰腺癌 | 局部晚期恶性实体瘤 | 不可切除的恶性实体肿瘤美国
-
University of ConnecticutUnited States Department of Defense; AMP Human; Park City, UT完全的
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South University完全的
-
Regeneron PharmaceuticalsBristol-Myers Squibb完全的
-
Zhejiang Hisun Pharmaceutical Co. Ltd.未知
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)完全的
-
Inozyme Pharma招聘中婴儿广泛性动脉钙化 | 常染色体隐性低血磷性佝偻病 | 外核苷酸焦磷酸酶/磷酸二酯酶 1 缺乏症美国, 英国
-
Inozyme Pharma招聘中婴儿广泛性动脉钙化 | 常染色体隐性低血磷性佝偻病 | 外核苷酸焦磷酸酶/磷酸二酯酶 1 缺乏症美国, 英国, 加拿大, 法国, 德国
-
Inozyme PharmaIQVIA Biotech主动,不招人
-
Yonsei University招聘中
-
Liverpool School of Tropical MedicineREACH Ethiopia; Bingham University完全的
-
Samsung Medical CenterDon-A Pharmaceutical, Seoul, South Korea未知
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.)终止
-
Umar FarooqMerck Sharp & Dohme LLC; University of Iowa; Checkmate Pharmaceuticals暂停
-
University of California, San FranciscoJohns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); Makerere University; Infectious Diseases Research Collaboration, Uganda主动,不招人
-
Diwakar DavarCellSight Technologies, Inc.; Checkmate Pharmaceuticals主动,不招人
-
Regeneron Pharmaceuticals暂停非小细胞肺癌 | 三阴性乳腺癌 | 默克尔细胞癌 | 基底细胞癌 | 口咽鳞状细胞癌 | 皮肤鳞状细胞癌美国, 澳大利亚